BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 33905297)

  • 1. Comparison of survival outcomes and effects of therapy between subtypes of high-grade endometrial cancer - a population-based study.
    Scharl S; Gerken M; Sprötge T; Kronberger K; Scharl A; Ignatov A; Ortmann O; Kölbl O; Klinkhammer-Schalke M; Papathemelis T
    Acta Oncol; 2021 Jul; 60(7):897-903. PubMed ID: 33905297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of polymerase epsilon (POLE) mutation in high-grade endometrioid endometrial cancer: Systematic review and meta-analysis.
    Casanova J; Duarte GS; da Costa AG; Catarino A; Nave M; Antunes T; Serra SS; Dias SS; Abu-Rustum N; Lima J
    Gynecol Oncol; 2024 Mar; 182():99-107. PubMed ID: 38262245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the utility of computed tomography in high-risk endometrial cancer surveillance.
    Lantsman T; Jansen C; Larson E; Esselen K; Shea M
    Cancer Treat Res Commun; 2024; 39():100812. PubMed ID: 38582032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Survival, Recurrence Patterns and Adjuvant Therapy in Surgically Staged High-Grade Endometrial Cancer with Retroperitoneal Metastases.
    McEachron J; Marshall L; Zhou N; Tran V; Kanis MJ; Gorelick C; Lee YC
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporating molecular profiling into endometrial cancer management requires prospective studies.
    Amant F; McCluggage WG; Werner HMJ; Kasius JC; Krakstad C; Pijnenborg J
    Int J Gynecol Cancer; 2021 Jun; 31(6):944-945. PubMed ID: 33962995
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of Molecular Classification on Treatment Paradigms in Uterine Cancers.
    Cosgrove CM; Barrington D; Backes FJ
    Curr Oncol Rep; 2021 May; 23(7):75. PubMed ID: 33937919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of the conservative management of the patients with endometrial intraepithelial neoplasia/endometrial cancer: Wait or treat!
    İşçi Bostancı E; Durmuş Y; Duru Çöteli AS; Kayıkçıoğlu F; Boran N
    Turk J Med Sci; 2021 Aug; 51(4):2066-2072. PubMed ID: 34013707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in patients with endometrial carcinoma: A Longitudinal Study.
    Chen J; Zou Q; Chen X; Liu X; Ding S; Mo Y; Yao S
    Nurs Open; 2022 May; 9(3):1815-1821. PubMed ID: 34009689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial Tumor Classification by Histomorphology and Biomarkers in the Nurses' Health Study.
    Watkins JC; Downing MJ; Crous-Bou M; Busch EL; Chen M; De Vivo I; Mutter GL
    J Cancer Epidemiol; 2021; 2021():8884364. PubMed ID: 33986807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of different routes of surgery for the management of endometrial cancer: a retrospective cohort study.
    Moss EL; Morgan G; Martin A; Sarhanis P; Ind T
    BMJ Open; 2021 May; 11(5):e045888. PubMed ID: 33986058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel Lymph Node Sampling as an Alternative to Lymphadenectomy in Patients With Endometrial Cancer and Obesity.
    Matanes E; Eisenberg N; Amajoud Z; Gupta V; Yasmeen A; Ismail S; Racovitan F; Raban O; Lau S; Salvador S; Gotlieb WH; Kogan L
    J Obstet Gynaecol Can; 2021 Oct; 43(10):1136-1144.e1. PubMed ID: 33984524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary clinical outcomes of patients treated with vaginal brachytherapy alone using multi-channel vaginal brachytherapy applicator in operated early-stage endometrial cancer.
    Rishi KS; David S; Pathikonda M; Ramachandra P; Giri GV; Vadaparty A; Srinath BS
    Rep Pract Oncol Radiother; 2021; 26(1):43-49. PubMed ID: 33948301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine serous carcinoma.
    Bogani G; Ray-Coquard I; Concin N; Ngoi NYL; Morice P; Enomoto T; Takehara K; Denys H; Nout RA; Lorusso D; Vaughan MM; Bini M; Takano M; Provencher D; Indini A; Sagae S; Wimberger P; Póka R; Segev Y; Kim SI; Candido Dos Reis FJ; Lopez S; Mariani A; Leitao MM; Raspagliesi F; Panici PB; Di Donato V; Muzii L; Colombo N; Scambia G; Pignata S; Monk BJ
    Gynecol Oncol; 2021 Jul; 162(1):226-234. PubMed ID: 33934848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793).
    Bellone S; Roque DM; Siegel ER; Buza N; Hui P; Bonazzoli E; Guglielmi A; Zammataro L; Nagarkatti N; Zaidi S; Lee J; Silasi DA; Huang GS; Andikyan V; Damast S; Clark M; Azodi M; Schwartz PE; Tymon-Rosario J; Harold J; Mauricio D; Zeybek B; Menderes G; Altwerger G; Ratner E; Alexandrov LB; Iwasaki A; Kong Y; Song E; Dong W; Elvin J; Choi J; Santin AD
    Ann Oncol; 2021 Aug; 32(8):1045-1046. PubMed ID: 33932502
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic signatures of greater body size and their associations with risk of colorectal and endometrial cancers in the European Prospective Investigation into Cancer and Nutrition.
    Kliemann N; Viallon V; Murphy N; Beeken RJ; Rothwell JA; Rinaldi S; Assi N; van Roekel EH; Schmidt JA; Borch KB; Agnoli C; Rosendahl AH; Sartor H; Huerta JM; Tjønneland A; Halkjær J; Bueno-de-Mesquita B; Gicquiau A; Achaintre D; Aleksandrova K; Schulze MB; Heath AK; Tsilidis KK; Masala G; Panico S; Kaaks R; Fortner RT; Van Guelpen B; Dossus L; Scalbert A; Keun HC; Travis RC; Jenab M; Johansson M; Ferrari P; Gunter MJ
    BMC Med; 2021 Apr; 19(1):101. PubMed ID: 33926456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG-PET/CT and Para-Aortic Staging in Endometrial Cancer. A French Multicentric Study.
    Sallée C; Margueritte F; Gouy S; Tardieu A; Belghiti J; Lambaudie E; Collinet P; Guyon F; Legros M; Monteil J; Gauthier T
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33920565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Signature Analysis Implicates Hereditary Cancer Genes in Endometrial Cancer Development.
    Kondrashova O; Shamsani J; O'Mara TA; Newell F; McCart Reed AE; Lakhani SR; Kirk J; Pearson JV; Waddell N; Spurdle AB
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33917078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective study for investigating the outcomes of endometrial cancer treated with radiotherapy.
    Sakai K; Yamagami W; Machida H; Ebina Y; Kobayashi Y; Tabata T; Kaneuchi M; Nagase S; Enomoto T; Aoki D; Mikami M
    Int J Gynaecol Obstet; 2022 Feb; 156(2):262-269. PubMed ID: 33914336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial Cancer, BRCA1, and BRCA2 in the UK Biobank Cohort.
    Lehrer S; Rheinstein PH
    Am J Clin Oncol; 2021 Jul; 44(7):299-300. PubMed ID: 34008499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Tumor Microenvironment-Related Alternative Splicing Events to Predict the Prognosis of Endometrial Cancer.
    Liu X; Liu C; Liu J; Song Y; Wang S; Wu M; Yu S; Cai L
    Front Oncol; 2021; 11():645912. PubMed ID: 33996564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.